BCLS ACQUISITION CORP's ticker is BLSA and the CUSIP is G0904B105. A total of 48 filers reported holding BCLS ACQUISITION CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,791,000 | +0.9% | 677,715 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $6,733,000 | -8.0% | 680,121 | -8.3% | 0.00% | 0.0% |
| Q1 2022 | $7,317,000 | +0.6% | 741,370 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $7,270,000 | -1.4% | 737,370 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $7,374,000 | -5.1% | 737,370 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $7,772,000 | -5.0% | 738,045 | -4.7% | 0.00% | 0.0% |
| Q1 2021 | $8,183,000 | -4.1% | 774,136 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,535,000 | – | 774,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 843,122 | $8,322,000 | 3.89% |
| Finepoint Capital LP | 603,429 | $5,956,000 | 1.98% |
| Logan Stone Capital, LLC | 210,276 | $2,075,000 | 1.50% |
| Samsara BioCapital, LLC | 300,000 | $2,961,000 | 0.74% |
| COMMODORE CAPITAL LP | 250,000 | $2,468,000 | 0.55% |
| Bain Capital Life Sciences Investors, LLC | 487,500 | $4,812,000 | 0.47% |
| Altium Capital Management LP | 100,000 | $987,000 | 0.33% |
| Exos Asset Management LLC | 71,039 | $701,000 | 0.30% |
| RA Capital Management | 1,250,000 | $12,338,000 | 0.27% |
| Boxer Capital, LLC | 500,000 | $4,935,000 | 0.25% |